This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Zinc cation
- DrugBank Accession Number
- DB14532
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Zinc cation (DB14532)
- Weight
- Average: 65.409
Monoisotopic: 63.929146578 - Chemical Formula
- Zn
- Synonyms
- Zinc ion
- Zinc ion(2+)
- Zinc, ion (Zn2+)
- Zinc(2+)
- Zinc(II)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Zinc deficiency •••••••••••• •••••••• •••••• Treatment of Zinc deficiency •••••••••••• •••••••• •••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareCabotegravir The serum concentration of Cabotegravir can be decreased when it is combined with Zinc cation. Carbamazepine Zinc cation can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy. Ceftibuten Zinc cation can cause a decrease in the absorption of Ceftibuten resulting in a reduced serum concentration and potentially a decrease in efficacy. Cephalexin Zinc cation can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy. Cinoxacin Zinc cation can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Orajel 3X Medicated For Toothache and Gum Zinc cation (1.5 mg/1g) + Benzocaine (200 mg/1g) + Levomenthol (2.6 mg/1g) Gel Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US 
Orajel 4X Medicated For Toothache and Gum Zinc cation (1.5 mg/1g) + Benzalkonium chloride (1.3 mg/1g) + Benzocaine (200 mg/1g) + Levomenthol (5 mg/1g) Gel Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US Orajel 4X Medicated For Toothache and Gum, Cream Zinc cation (1.5 mg/1g) + Benzalkonium chloride (1.3 mg/1g) + Benzocaine (200 mg/1g) + Levomenthol (2.6 mg/1g) Cream Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US Orajel 4X Medicated For Toothache and Gum, Cream Zinc cation (1.5 mg/1g) + Benzalkonium chloride (1.3 mg/1g) + Benzocaine (200 mg/1g) + Menthol (2.6 mg/1g) Cream Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US Orajel 4X Medicated PM For Toothache and Gum Zinc cation (1.5 mg/1g) + Benzalkonium chloride (1.3 mg/1g) + Benzocaine (200 mg/1g) + Levomenthol (2.6 mg/1g) Cream Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 13S1S8SF37
- CAS number
- 23713-49-7
- InChI Key
- PTFCDOFLOPIGGS-UHFFFAOYSA-N
- InChI
- InChI=1S/Zn/q+2
- IUPAC Name
- zinc(2+) ion
- SMILES
- [Zn++]
References
- General References
- Not Available
- External Links
- PDB Entries
- 12ca / 1a0b / 1a0q / 1a1f / 1a1g / 1a1h / 1a1i / 1a1j / 1a1k / 1a1l … show 22111 more
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Topical Cream Topical Tablet, delayed release Oral 10 mg Capsule Oral 15 mg Tablet 25 mg Tablet, film coated Oral 25 mg - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 0.16 Chemaxon pKa (Strongest Acidic) 3.09 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 0 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 12, 2018 19:44 / Updated at May 05, 2022 18:00